Imaging of the gastrointestinal complications of systemic chemotherapy

Clinical Radiology

Volumn 64, Issue 7, 2009, Pages 724-733

  Cronin, C G ^a   O'Connor, M ^a   Lohan, D G ^a   Keane, M ^a   Roche, C ^a   Bruzzi, J F ^a   Murphy, J M ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IMATINIB; INTERLEUKIN 2; IRINOTECAN; MITOMYCIN; NAVELBINE; OXALIPLATIN; PACLITAXEL; PREDNISOLONE; TRASTUZUMAB; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ANOREXIA; BREAST CANCER; CANCER CHEMOTHERAPY; COLITIS; COLON ULCER; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIARRHEA; DIGESTIVE SYSTEM FISTULA; DIGESTIVE SYSTEM INJURY; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DRUG INDUCED DISEASE; ENTEROCOLITIS; ESOPHAGITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL STROMAL TUMOR; HODGKIN DISEASE; HUMAN; ILEUS; INTESTINE OBSTRUCTION; ISCHEMIC COLITIS; KIDNEY CARCINOMA; LEUKEMIA; LUNG CANCER; MEGACOLON; MELANOMA; NASOPHARYNX CANCER; NEUTROPENIA; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; REVIEW; SIDE EFFECT; TESTIS CANCER; TYPHLITIS; UTERINE CERVIX CANCER; WEIGHT REDUCTION; WOUND HEALING IMPAIRMENT;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ENTEROCOLITIS, NEUTROPENIC; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINAL PERFORATION; MALE; MIDDLE AGED; STOMACH ULCER; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67349239861     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2009.02.016     Document Type: Review

References (53)

1. Pear B.L. Pneumatosis intestinalis: a review. Radiology 207 (1998) 13-19
2. Davila M.L. Neutropenic enterocolitis. Curr Opin Gastroenterol 22 (2006) 44-47
3. Hortobagyi G.N., Frye D., Buzdar A.U., et al. Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma. Cancer 63 (1989) 37-45
4. Kennedy M.J., Zahurak M.L., Donehower R.C., et al. Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancer. J Clin Oncol 14 (1996) 783-791
5. Fleming R.A., Miller A.A., and Stewart C.F. Etoposide: an update. Clin Pharm 8 (1989) 274-293
6. Dunton C.J. Management of treatment-related toxicity in advanced ovarian cancer. Oncologist 7 (2002) 11-19
7. D'Amato G., Lima C.R., Mahany J.J., et al. Neutropenic enterocolitis (typhlitis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature. Lung Cancer 44 (2004) 381-390
8. Li Z., Ibrahim N.K., Wathen J.K., et al. Colitis in patients with breast carcinoma treated with taxane-based chemotherapy. Cancer 101 (2004) 1508-1513
9. Daniele B., Rossi G.B., Losito S., et al. Ischaemic colitis associated with paclitaxel. J Clin Gastroenterol 33 (2001) 159-160
10. Resnik E., and Lefevre C.A. Fulminant Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy. Int J Gynecol Cancer 9 (1999) 512-514
11. Seewaldt V., Cain J.M., Greer B.E., et al. Bowel complications with taxol therapy. J Clin Oncol 11 (1993) 1198
12. Keidan R.D., Fanning J., Gatenby R.A., et al. Recurrent typhlitis, a disease resulting from aggresive chemotherapy. Dis Colon Rectum 32 (1989) 206-209
13. Petalozzi B.C., Sotos G.A., Choyke P.L., et al. Typhlitis resulting from treatment with Taxol and doxorubicin in patients with metastatic breast cancer. Cancer 71 (1993) 1797-1800
14. Epstein M., Chiu A., Medina P., et al. Typhlitis, clostridia septicum bacteraemia, and septic arthritis after treatment with paclitaxel and carboplatin in a patient with non-small cell lung cancer. Cancer Ther 1 (1998) 174-177
15. Rose P.G., and Piver M.S. Intestinal perforation secondary to paclitaxel. Gynecol Oncol 57 (1995) 270-272
16. Feldman. Sleisenger & Fordtran's Gastrointestinal and Liver Disease, 8th ed. Chapter 120. 2006. Available at: http://phstwlp1.partners.org:2872/about/book/saunders.html.
17. Kennedy B.J. 5-Fluorouracil toxicity. Cancer 86 (1999) 1099-1100
18. Gizzi G., Biasco G., Villani V., et al. Endoscopic evidence of GI haemorrhage induced by 5-fluorouracil administration. Gastrointest Endosc 57 (2003) 785-787
19. Ter R.B., Infantolino A., Leite L.P., et al. Gastrointestinal ulceration and haemorrhage from hepatic arterial infusion chemotherapy. Gastrointest Endosc 49 (1999) 92
20. Kelvin F.M., Gramm H.F., Gluck W.L., et al. Radiologic manifestations of small-bowel toxicity due to floxuridine therapy. AJR Am J Roentgenol 146 (1986) 39-43
21. Saif M.W., Elfiky A., and Salem R.R. Gastrointestinal perforation due to bevacizumab in colorectal cancer. Ann Surg Oncol 14 (2007) 1860-1869
22. Gray J., Murren J., Sharma A., et al. Perforated viscus in a patient with non-small cell lung cancer receiving bevacizumab. J Thorac Oncol 2 (2007) 571-573
23. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
24. Demetri G.D., von Mehren M., Blanke C.D., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumours. N Engl J Med 347 (2002) 472
25. Heimann D.M., and Schwartzentruber D.J. Gastrointestinal perforations associated with interleukin-2 administration. J Immunother 27 (2004) 254-258
26. Furonaka M., Miyazaki M., Nakajima M., et al. Neutropenic enterocolitis in lung cancer: a report of two cases and a review of the literature. Intern Med 44 (2005) 467-470
27. Vlasveld L.T., Zwaan F.E., Fibbe W.E., et al. Neutropenic enterocolitis following treatment with cytosine arabinoside-containing regimens for hematological malignancies: a potentiating role for amsacrine. Ann Hematol 62 (1991) 129-134
28. Tjon A., Tham R.T., Vlasveld L.T., et al. Gastrointestinal complications of cytosine-arabinoside chemotherapy: findings on plain abdominal radiographs. AJR Am J Roentgenol 154 (1990) 95-98
29. Jones G.T., and Abramson N. Gastrointestinal necrosis in acute leukemia: a complication of induction therapy. Cancer Invest 1 (1983) 315-320
30. Dincol D., Icli F., Erekul S., et al. Primary gastrointestinal lymphomas in Turkey: a retrospective analysis of clinical features and results of treatment. J Surg Oncol 51 (1992) 270-273
31. Haim N., Leviov M., Ben Arieh Y., et al. Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy. Leuk Lymphoma 17 (1995) 321-326
32. Toghill P.J., and Burke J.D. Death from paralytic ileus following vincristin therapy. Postgrad Med J 46 (1970) 330-331
33. Rosenberg R.F., and Caridi J.D. Vincristin-induced megacolon. Gastrointest Radiol 8 (1983) 71-73
34. Büyükaşik Y., Ozcebe O.I., Haznedaroǧlu I.C., et al. Neutropenic enterocolitis in adult leukemias. Int J Hematol 66 (1997) 47-55
35. Camera A., Andretta C., Villa M.R., et al. Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia. Hematol J 4 (2003) 346-350
36. Frick M.P., Maile C.W., Crass J.R., et al. Computed tomography of neutropenic colitis. AJR Am J Roentgenol 143 (1984) 763-765
37. Kirkpatrick I.D., and Greenberg H.M. Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT. Radiology 226 (2003) 668-674
38. Kirkpatrick I.D.C., and Greenberg H.M. Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy?. AJR Am J Roentgenol 176 (2001) 635-639
39. Boland G.W., Lee M.J., Cats A.M., et al. Antibiotic-induced diarrhea: specificity of abdominal CT for the diagnosis of Clostridium difficile disease. Radiology 191 (1994) 103-106
40. Shamberger R.C., Weinstein H.J., Delorey M.J., et al. The medical and surgical management of typhlitis in children with acute non-lymphocytic (myelogenous) leukemia. Cancer 57 (1986) 603-609
41. Philpotts L.E., Heiken J.P., Westcott M.A., et al. Colitis: use of CT findings in differential diagnosis. Radiology 190 (1994) 445-449
42. Ash L., Baker M.E., O'Malley Jr. C.M., et al. Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings. AJR Am J Roentgenol 186 (2006) 1393-1400
43. Macari M., Balthazar E.J., and Megibow A.J. The accordion sign on CT: a nonspecific finding in patients with colonic oedema. Radiology 211 (1999) 743-746
44. Talamonti M.S., Dawes L.G., Joehl R.J., et al. Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg 125 (1990) 972-977
45. Meyers P.A., Potter V., Wollner N., et al. Bowel perforation during initial treatment for childhood non-Hodgkin's lymphoma. Cancer 56 (1985) 259-261
46. Liaw C.C., Huang J.S., Wang H.M., et al. Spontaneous gastroduodenal perforation in patients with cancer receiving chemotherapy and steroids. Cancer 72 (2006) 1382-1385
47. Schwartzentruber D., Lotze M.T., and Rosenberg S.A. Colonic perforation. An unusual complication of therapy with high-dose interleukin-2. Cancer 62 (1988) 2350-2353
48. Traina T.A., Norton L., Drucker K., et al. Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer. Oncologist 11 (2006) 1070
49. Nielsen G.L., Sorensen H.T., Mellemkjoer L., et al. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study. Am J Med 111 (2001) 541-545
50. Allerton R. Acute mesenteric ischemia associated with 5-FU, cisplatin, and vincristine chemotherapy. Clin Oncol 8 (1996) 116-117
51. Matolo N.M., Garfinkle S.E., and Wolfman Jr. E.F. Intestinal necrosis and perforation in patients receiving immunosuppressive drugs. Am J Surg 132 (1976) 753-754
52. Theodossiou C., Kroog G., and Ettinghausen S. Acute arterial thrombosis in a patient with breast cancer after chemotherapy with 5-fluorouracil, doxorubicin, leucovorin, cyclophosphamide, and interleukin-3. Cancer 74 (1994) 2808-2810
53. Schmitt M., Kuhn W., and Harbeck N. Thrombophylic state in breast cancer. Semin Thromb Hemost 25 (1999) 157-166